Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2006 December;58(6) > Minerva Ginecologica 2006 December;58(6):489-97

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

REVIEWS   

Minerva Ginecologica 2006 December;58(6):489-97

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: Italian

Ovulation induction in anovulatory women

La Marca A., Bertucci E., Giulini S., Tirelli A., Malavasi B., Volpe A.

Sezione di Ginecologia e Ostetricia Dipartimento Materno Infantile Università degli Studi di Modena e Reggio Emilia, Modena


PDF


Ovulation induction therapy is administered to stimulate follicular growth and induce ovulation in anovulatory infertile women. In anovulatory women with polycystic ovary syndrome, the treatment of choice is clomiphene citrate, whereas in clomiphene nonresponders, gonadotrophins are given as secondary therapy. Currently, insulin-sensitizing agents are used in the treatment of polycystic ovary syndrome to restore menstrual cyclicity. In selected patients, laparoscopic drilling has also been suggested. In anovulatory patients affected with hypogonadotropic hypogonadism, treatment is based on gonadotrophin replacement therapy or pulsatile gonadotrophin-releasing hormone infusion. In ovulation induction therapy the clinician’s attention should be directed at restoring normal ovary function. When pharmacotherapy is required, monofollicular growth should be induced to reduce the risk of multiple pregnancy.

top of page